SEC-sourced researchBeta

YDES

YD Bio Ltd

US markets

Data passport

CIK: 0002011674
Exchange: Nasdaq
Business activity: — · SIC 8071
Financial inputs: 6/6
Filing date: Oct 6, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 8:04 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

YDES · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2023	350,131.0000	Apr 30, 2026
December 2024	510,360.0000	Apr 30, 2026
December 2025	596,817.0000	Apr 30, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	596,817.0000	-8,311,316.0000	-6,596,706.0000	13,779,397.0000	16,635,060.0000	Apr 30, 2026
December 2024	510,360.0000	-1,411,559.0000	-1,222,681.0000	6,864,226.0000	273,980.0000	Apr 30, 2026
December 2023	350,131.0000	13,560.0000	-55,657.0000	—	—	Apr 30, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenues	$596.82K	December 2025	Apr 30, 2026	20-F
Previous period revenueRevenues	$510.36K	December 2024	Apr 30, 2026	20-F
Net incomeNetIncomeLoss	-$8.31M	December 2025	Apr 30, 2026	20-F
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$6.6M	December 2025	Apr 30, 2026	20-F
Total assetsAssets	$13.78M	December 2025	Apr 30, 2026	20-F
Total liabilitiesLiabilities	$16.64M	December 2025	Apr 30, 2026	20-F

New filings

Explore methodology ↗